Axonics Inc (NASDAQ: AXNX) open the trading on Wednesday, with a bit cautious approach as it glided -0.07% to $67.70, before settling in for the price of $67.75 at the close. Taking a more long-term approach, AXNX posted a 52-week range of $47.59-$69.68.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 541.82%. Meanwhile, its Annual Earning per share during the time was 36.15%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 399.34%. This publicly-traded company’s shares outstanding now amounts to $50.77 million, simultaneously with a float of $50.44 million. The organization now has a market capitalization sitting at $3.45 billion. At the time of writing, stock’s 50-day Moving Average stood at $68.08, while the 200-day Moving Average is $59.90.
Axonics Inc (AXNX) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Devices industry. Axonics Inc’s current insider ownership accounts for 1.10%, in contrast to 100.85% institutional ownership. According to the most recent insider trade that took place on Jan 31 ’24, this organization’s Chief Executive Officer sold 35,161 shares at the rate of 67.74, making the entire transaction reach 2,381,662 in total value, affecting insider ownership by 188,835. Preceding that transaction, on Jan 31 ’24, Company’s Chief Commercial Officer sold 16,615 for 67.74, making the whole transaction’s value amount to 1,125,432. This particular insider is now the holder of 43,450 in total.
Axonics Inc (AXNX) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 12/30/2023 suggests? It has posted $0.13 earnings per share (EPS) beating the forecaster’s viewpoint (set at $0.06) by $0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.15 per share during the current fiscal year.
Axonics Inc’s EPS increase for this current 12-month fiscal period is 399.34% and is forecasted to reach 0.71 in the upcoming year.
Axonics Inc (NASDAQ: AXNX) Trading Performance Indicators
Let’s observe the current performance indicators for Axonics Inc (AXNX). It’s Quick Ratio in the last reported quarter now stands at 8.98. The Stock has managed to achieve an average true range (ATR) of 0.52. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 9.42.
In the same vein, AXNX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.13, a figure that is expected to reach -0.05 in the next quarter, and analysts are predicting that it will be 0.71 at the market close of one year from today.
Technical Analysis of Axonics Inc (AXNX)
[Axonics Inc, AXNX] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 6.86% While, its Average True Range was 0.50.
Raw Stochastic average of Axonics Inc (AXNX) in the period of the previous 100 days is set at 86.43%, which indicates a major rise in contrast to 5.74% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 13.49% that was lower than 36.16% volatility it exhibited in the past 100-days period.
